|
UA73073C2
(uk)
*
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6002008A
(en)
*
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
AUPP003197A0
(en)
*
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
|
HUP0101275A3
(en)
|
1998-03-26 |
2002-12-28 |
Japan Tobacco Inc |
Amide derivatives and pharmaceutical compositions containing them as nociceptin antagonists
|
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
GB9822440D0
(en)
|
1998-10-14 |
1998-12-09 |
Smithkline Beecham Plc |
Medicaments
|
|
AU5250400A
(en)
*
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
|
AU6865100A
(en)
*
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
|
SE9903611D0
(sv)
*
|
1999-10-06 |
1999-10-06 |
Astra Ab |
Novel compounds III
|
|
DE60143041D1
(de)
|
2000-08-10 |
2010-10-21 |
Pfizer Italia Srl |
Bizyklische pyrazole wirksam als kinase inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
|
|
DE10060145C1
(de)
*
|
2000-12-04 |
2002-06-13 |
Michael Wackernagel |
Chinolin-Derivate, ihre Verwendung und diese enthaltende pharmazeutische Zusammensetzung
|
|
CA2430951A1
(en)
*
|
2000-12-07 |
2002-06-13 |
Cv Therapeutics, Inc. |
Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
|
|
AR038658A1
(es)
*
|
2001-06-15 |
2005-01-26 |
Novartis Ag |
Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
|
|
GB0130341D0
(en)
*
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
|
GB0230015D0
(en)
*
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
|
UA80607C2
(en)
*
|
2003-04-09 |
2007-10-10 |
White Holdings Corp |
Process for the preparation of 3-cyano-6-alkoxy-7-nitro-4-quinolines
|
|
DE10331675A1
(de)
*
|
2003-07-14 |
2005-02-10 |
Bayer Cropscience Ag |
Hetarylsubstituierte Pyrazolidindion-Derivate
|
|
JP4667384B2
(ja)
|
2003-10-07 |
2011-04-13 |
レノビス， インコーポレイテッド |
イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
|
|
SI1746999T1
(sl)
*
|
2004-05-06 |
2012-01-31 |
Warner Lambert Co |
4-fenilamino-kinazolin-6-il-amidi
|
|
WO2005108404A1
(ja)
*
|
2004-05-12 |
2005-11-17 |
Ube Industries, Ltd. |
エチニル基置換縮合ヘテロ環化合物重金属錯体、その製造法、その合成中間体及びその製造法並びに有機エレクトロルミネッセンス素子
|
|
FR2874922A1
(fr)
*
|
2004-07-30 |
2006-03-10 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
WO2006024741A2
(fr)
*
|
2004-07-30 |
2006-03-09 |
Palumed S.A. |
Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
FR2873695A1
(fr)
*
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
WO2006040645A1
(en)
*
|
2004-10-11 |
2006-04-20 |
Ranbaxy Laboratories Limited |
N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
|
|
US7875627B2
(en)
*
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
CA2599688A1
(en)
|
2005-03-01 |
2006-09-08 |
Wyeth |
Cinnoline compounds and their use as liver x receptor modulators
|
|
DE602006016564D1
(de)
*
|
2005-03-03 |
2010-10-14 |
Santen Pharmaceutical Co Ltd |
Neue cyclische verbindung mit chinolylalkylthiogruppe
|
|
EP1991540A1
(en)
*
|
2006-02-21 |
2008-11-19 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
US20090099175A1
(en)
*
|
2006-03-01 |
2009-04-16 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
AU2007223801A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
CA2685888A1
(en)
*
|
2007-05-09 |
2008-11-20 |
Pfizer Inc. |
Substituted heterocyclic derivatives and their pharmaceutical use and compositions
|
|
US20110038852A1
(en)
*
|
2009-06-10 |
2011-02-17 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
|
CN103539734B
(zh)
*
|
2013-09-25 |
2015-10-14 |
上海交通大学 |
3-烯丙基喹啉的制备方法
|
|
WO2016032569A1
(en)
*
|
2014-08-29 |
2016-03-03 |
Celladon Corporation |
Quinolines and their use for treating endoplasmic reticulum stress-caused diseases
|
|
US20200347038A1
(en)
|
2014-08-29 |
2020-11-05 |
Russell Dahl |
Quinolines that modulate serca and their use for treating disease
|
|
US9932310B2
(en)
*
|
2016-02-08 |
2018-04-03 |
City Of Hope |
DNA2 inhibitors for cancer treatment
|
|
US11730729B2
(en)
|
2020-07-20 |
2023-08-22 |
Neurodon Corporation |
Quinolines that modulate SERCA and their use for treating disease
|
|
US12486269B2
(en)
|
2024-02-08 |
2025-12-02 |
Aconcagua Bio, Inc. |
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
|
|
WO2025171341A2
(en)
*
|
2024-02-08 |
2025-08-14 |
Aconcagua Bio, Inc. |
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
|